Purchases and Sales Made in Q4 2024 in Legend Biotech Corp (LEGN)
This table provides information about the institutional ownership of Legend Biotech Corp (LEGN) during Q4 2024. The information is specifically focused on institutions that hold shares of Legend Biotech Corp.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 13, 2025
Q4 2024
|
Ray Dalio
Bridgewater Associates, LP | Westport, Ct
|
SELL
|
- |
-4.25K- 2.56% |
$138K - $214K
|
162K
$5.61M
|
|
Jan 30, 2025
Q4 2024
|
Ronald Blue Trust, Inc.
Brentwood, TN |
SELL
|
- |
-5.52K- 94.5% |
$179K - $277K
|
321
$11.1K
|
|
Feb 14, 2025
Q4 2024
|
Vident Advisory, LLC
Alpharetta, GA |
SELL
|
- |
-5.57K- 24.19% |
$181K - $280K
|
17.5K
$606K
|
|
Feb 14, 2025
Q4 2024
|
Hsbc Holdings PLC
London, X0 |
SELL
|
- |
-6.49K- 1.64% |
$211K - $327K
|
389K
$13.5M
|
|
Feb 11, 2025
Q4 2024
|
Td Asset Management Inc
|
SELL
|
- |
-8.2K- 7.06% |
$266K - $412K
|
108K
$3.75M
|
|
Feb 13, 2025
Q4 2024
|
Capital International Sarl
Los Angeles, CA |
SELL
|
- |
-9.01K- 14.22% |
$293K - $453K
|
54.3K
$1.89M
|
|
Feb 10, 2025
Q4 2024
|
Skandinaviska Enskilda Banken Ab (Publ)
Stockholm, V7 |
SELL
|
- |
-9.2K- 74.8% |
$299K - $463K
|
3.1K
$108K
|
|
Feb 07, 2025
Q4 2024
|
Zurcher Kantonalbank (Zurich Cantonalbank)
Zurich, V8 |
SELL
|
- |
-9.36K- 18.61% |
$304K - $470K
|
40.9K
$1.42M
|
|
Feb 14, 2025
Q4 2024
|
Exome Asset Management LLC
New York, NY |
SELL
|
- |
-9.4K- 20.0% |
$305K - $473K
|
37.6K
$1.3M
|
|
Jan 21, 2025
Q4 2024
|
E Fund Management (Hong Kong) Co., Ltd.
|
SELL
|
- |
-10.6K- 19.79% |
$345K - $534K
|
43.1K
$1.49M
|
|
Feb 12, 2025
Q4 2024
|
Massachusetts Financial Services CO
Boston, MA |
SELL
|
- |
-11.6K- 0.51% |
$377K - $583K
|
2.26M
$78.5M
|
|
Feb 12, 2025
Q4 2024
|
Neos Investment Management LLC
Westport, CT |
SELL
|
- |
-12.5K- 52.46% |
$407K - $630K
|
11.4K
$394K
|
|
Feb 13, 2025
Q4 2024
|
Polymer Capital Management (Hk) LTD
Hong Kong, K3 |
SELL
|
- |
-13.1K- 31.32% |
$426K - $659K
|
28.7K
$997K
|
|
Jan 27, 2025
Q4 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-13.9K- 48.51% |
$450K - $696K
|
14.7K
$510K
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-19.9K- 1.75% |
$647K - $1M
|
1.12M
$38.9M
|
|
Feb 12, 2025
Q4 2024
|
Korea Investment Corp
Seoul, M5 |
SELL
|
- |
-21.1K- 49.54% |
$686K - $1.06M
|
21.5K
$746K
|
|
Feb 14, 2025
Q4 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-28.9K- 1.32% |
$938K - $1.45M
|
2.16M
$74.8M
|
|
Feb 13, 2025
Q4 2024
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-30.6K- 11.12% |
$995K - $1.54M
|
245K
$8.5M
|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-33.8K- 21.07% |
$1.1M - $1.7M
|
127K
$4.39M
|
|
Feb 13, 2025
Q4 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-49.4K- 3.21% |
$1.61M - $2.48M
|
1.49M
$51.7M
|
|
Feb 14, 2025
Q4 2024
|
Lmr Partners LLP
London, X0 |
SELL
|
- |
-57.2K- 45.98% |
$1.86M - $2.88M
|
67.2K
$2.33M
|
|
Feb 13, 2025
Q4 2024
|
Capital International Investors
Los Angeles, CA |
SELL
|
- |
-62.9K- 2.83% |
$2.04M - $3.16M
|
2.16M
$75M
|
|
Feb 14, 2025
Q4 2024
|
Polar Capital Holdings PLC
London, X0 |
SELL
|
- |
-114K- 23.05% |
$3.72M - $5.75M
|
382K
$13.3M
|
|
Feb 13, 2025
Q4 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-133K- 26.86% |
$4.31M - $6.68M
|
362K
$12.5M
|
|
Feb 13, 2025
Q4 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-194K- 39.28% |
$6.3M - $9.75M
|
300K
$10.4M
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-315K- 55.21% |
$10.2M - $15.8M
|
255K
$8.86M
|
|
Feb 14, 2025
Q4 2024
|
Hhlr Advisors, Ltd.
Grand Cayman, E9 |
SELL
|
- |
-652K- 9.82% |
$21.2M - $32.8M
|
5.98M
$208M
|
|
Feb 03, 2025
Q4 2024
|
Times Square Capital Management, LLC
|
SELL
|
- |
-1.16M- 99.75% |
$37.6M - $58.1M
|
2.91K
$101K
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-4.36M- 39.03% |
$142M - $219M
|
6.81M
$236M
|